63
Views
5
CrossRef citations to date
0
Altmetric
Original Research

A genetic approach to the prediction of drug side effects: bleomycin induces concordant phenotypes in mice of the collaborative cross

, , , , , & show all
Pages 35-45 | Published online: 04 Jul 2011

References

  • LazoJSHoytDGThe molecular basis of interstitial pulmonary fibrosis caused by antineoplastic agentsCancer Treat Rev1990172–31651671703044
  • LeviJRaghavenDHarveyVThe importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinomaJ Clin Oncol1993117130013057686216
  • SimpsonABPaulJGrahamJKayeSBFatal bleomycin pulmonary toxicity in the west of Scotland 1991–1995: a review of patients with germ cell tumorsBr J Cancer1998788106110669792151
  • SleijferSBleomycin-induced pneumonitisChest2001120261762411502668
  • SchrierDJJunkelRGPhanSHThe role of strain variation in murine bleomycin-induced pulmonary fibrosisAm Rev Respir Dis1983127163666185026
  • EkimotoHTakadaKOhnukiTDifferent sensitivity to bleomycin-induced pulmonary fibrosis among various strains of miceJ Clin Biochem Nutr1987212531
  • HastonCKWangMDejournettREBleomycin hydrolase and a genetic locus within the MHC affect risk for pulmonary fibrosis in miceHum Mol Genet200211161855186312140188
  • BarthRKHanchettLABaecher-AllanCMMapping susceptibility genes for the induction of pulmonary fibrosis in miceChest2002121Suppl 321S11893659
  • LemayAMHastonCKBleomycin-induced pulmonary fibrosis susceptibility genes in AcB/BcA recombinant congenic micePhysiol Genomics2005231546116179420
  • ChurchillGAAireyDCAllayeeHThe Collaborative Cross, a community resource for the genetic analysis of complex traitsNat Genet200436111133113715514660
  • CheslerEJMillerDRBranstetterLRThe Collaborative Cross at Oak Ridge National Laboratory: developing a powerful resource for systems geneticsMamm Genome200819638238918716833
  • RobertsAPardo-Manuel de VillenaFWangWMcMillanLThreadgillDWThe polymorphism architecture of mouse genetic resources elucidated using genome-wide resequencing data: implications for QTL discovery and systems geneticsMamm Genome2007186–747348117674098
  • BaranCPOpalekJMMcMakenSImportant roles for macrophage colony-stimulating factor, CC chemokine ligand 2, and mononuclear phagocytes in the pathogenesis of pulmonary fibrosisAm J Respir Crit Care Med20071761788917431224
  • WangKZhangSMarzolfBCirculating microRNAs, potential biomarkers for drug-induced liver injuryProc Natl Acad Sci U S A2009106114402440719246379
  • ChoJHGelinasRWangKSystems biology of interstitial lung diseases: integration of mRNA and microRNA expression changesBMC Medical Genomics20114821241464
  • PanditKVCorcoranDYousefHInhibition and role of let-7d in idiopathic pulmonary fibrosisAm J Respir Crit Care Med2010182222022920395557
  • D’CruzDAutoimmune diseases associated with drugs, chemicals and environmental factorsToxicol Lett2000112–113421432
  • YoshizakiAIwataYKomuraKCD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced sclerodermaAm J Pathol200817261650166318467694
  • IshikawaHItoSNishioNYuzawaYMatsuoSIsobeKInjection of bleomycin in newborn mice induces autoimmune sialitis that is transferred by CD4 T cellsImmunol Cell Biol200987435135819204734
  • KomuraKYanabaKHorikawaMCD19 regulates the development of bleomycin-induced pulmonary fibrosis in a mouse modelArthritis Rheum200858113574358418975313
  • IshikawaHTakedaKOkamotoAMatsuoSIsobeKInduction of autoimmunity in a bleomycin-induced murine model of experimental systemic sclerosis: an important role for CD4+ T cellsJ Invest Dermatol200912971688169519158840